A Phase 1 Study to Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants
Status:
Recruiting
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate safety and tolerability data when SRSD107
is administered as single and multiple SC injections to healthy participants. This
information, along with PK/PD data, will help establish the appropriate doses and dosing
regimen for future studies in patients.